机构

• 合肥物质科学研究院 [5]
• 上海药物研究所 [2]

采集方式

• OAI收割 [7]

内容类型

• 期刊论文 [6]
• 会议论文 [1]

发表日期

• 2022 [2]
• 2021 [2]
• 2020 [1]
• 2016 [1]
• 2015 [1]

学科主题

筛选

浏览/检索结果: 共7条，第1-7条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements 期刊论文  OAI收割 LIVER CANCER, 2022, 卷号: 11 作者:  Sun, Yongkun;  Zhang, Wen;  Bi, Xinyu;  Yang, Zhengqiang;  Tang, Yu   |  收藏  |  浏览/下载：38/0  |  提交时间：2022/12/23 Chinese interdisciplinary experts  Hepatocellular carcinoma  Molecular targeted therapy  Consensus   Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR) 期刊论文  OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Jin, Jing;  Tang, Yuan;  Hu, Chen;  Jiang, Li-Ming;  Jiang, Jun   |  收藏  |  浏览/下载：21/0  |  提交时间：2022/12/23 Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial 期刊论文  OAI收割 CLINICAL CANCER RESEARCH, 2021, 卷号: 27 作者:  Li, Dapeng;  Chi, Yihebali;  Chen, Xiaohong;  Ge, Minghua;  Zhang, Yuan   |  收藏  |  浏览/下载：40/0  |  提交时间：2021/08/31 Anlotinib in radioiodine-refractory differentiated thyroid carcinoma: A subanalysis based on ALTER01032 study for patients with poor baseline characteristics. 期刊论文  OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Chi, Yihebali;  Gao, Ming;  Zhang, Yuan;  Shi, Feng;  Cheng, Ying   |  收藏  |  浏览/下载：24/0  |  提交时间：2022/01/10 Health-related quality-of-life results from SANET-ep: A phase III study of surufatinib versus placebo for advanced extrapancreatic neuroendocrine tumors. 期刊论文  OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2020, 卷号: 38 作者:  Bai, Chunmei;  Xu, Jianming;  Shen, Lin;  Li, Jie;  Zhou, Zhiwei   |  收藏  |  浏览/下载：55/0  |  提交时间：2020/11/30 Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors 期刊论文  OAI收割 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 卷号: 9 作者:  Sun, Yongkun;  Niu, Wei;  Du, Feng;  Du, Chunxia;  Li, Shuting   |  收藏  |  浏览/下载：35/0  |  提交时间：2019/01/08 Anlotinib  Anti-angiogenesis  Phase I study  Advanced refractory solid tumors  Pharmacokinetics  Safety   Safety, pharmacokinetic, and antitumor activity of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors. 会议论文  OAI收割 作者:  Sun, Yongkun;  Niu, Wei;  Chi, Yihebali;  Li, Chuan;  Du, Chun-Xia   |  收藏  |  浏览/下载：18/0  |  提交时间：2019/01/08